Travaux scientifiques

Doç. Dr. Berkan Armağan

299 publications. La source de l’information est indiquée à côté de chaque publication.

Retour au profil
  1. Diagnostic Yield of Internal Medicine Referrals to Rheumatology: A Retrospective Single-Center Study

    Medicina, 2026

    DOI 10.3390/medicina62101943 PMID 42942472 Texte intégral en libre accèsSource : ORCID

  2. Can baseline features predict progression to defined connective tissue disease? Insights from a minimum 5-year follow-up study of 504 patients with undifferentiated connective tissue disease: A retrospective study

    Modern rheumatology, 2026

    DOI 10.1093/mr/roag006 PMID 41670330 Source : Europe PMC

  3. Does vascular involvement affect erectile dysfunction in patients with Behçet's disease?: a single-center cross-sectional study

    Sao Paulo medical journal = Revista paulista de medicina, 2026

    DOI 10.1590/1516-3180.2025.3295.12062026 PMID 42788553 Texte intégral en libre accèsSource : Europe PMC

  4. Do different organ involvements cause different comorbidity profiles in Behçet's syndrome?

    Postgraduate medicine, 2026

    DOI 10.1080/00325481.2026.2641859 PMID 41797226 Source : Europe PMC

  5. Screening of osteoporosis in patients with ANCA-associated vasculitis (AAV) is quite low: results from a country-wide study

    Internal and emergency medicine, 2026

    DOI 10.1007/s11739-026-04349-3 PMID 41946942 Texte intégral en libre accèsSource : Europe PMC

  6. Predictors of Cyclophosphamide Resistance in Granulomatosis with Polyangiitis: A Retrospective Cohort Study

    Mediterranean Journal of Rheumatology, 2026

    DOI 10.31138/mjr.150736.pcr PMID 42100069 Texte intégral en libre accèsSource : OpenAlex

  7. Frequency and clinical effect of the presence of anti-DFS70 antibodies in a large cohort of patients with undifferentiated connective tissue disease

    Irish journal of medical science, 2026

    DOI 10.1007/s11845-026-04408-w PMID 42029815 1 citation (Europe PMC) Source : Europe PMC

  8. Turkish Society for Rheumatology recommendations for topical and systemic treatments in Sjögren's disease

    Clinical and Experimental Rheumatology, 2026

    DOI 10.55563/clinexprheumatol/li5fmv PMID 42814613 Texte intégral en libre accèsSource : OpenAlex

  9. Venous Thromboembolism May Be Increased in the Early Phases of ANCA ‐Associated Vasculitis and Could Be Associated With a High Body Mass Index: TR ‐ VaS Experience

    International Journal of Rheumatic Diseases, 2025

    DOI 10.1111/1756-185x.70506 PMID 41408677 Source : OpenAlex

  10. The relationship of plasma netrin-1 level with disease activity and other parameters in patients with axial spondyloarthritis

    Cytokine, 2025

    DOI 10.1016/j.cyto.2025.157055 PMID 41092515 Source : OpenAlex

  11. Medication adherence and real-world factors of first line induction treatment selection in ANCA-associated vasculitis

    Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 2025

    DOI 10.36141/svdld.v42i3.16880 PMID 41026025 Texte intégral en libre accèsSource : Europe PMC

  12. Novel inflammatory biomarkers for discriminating vascular involvement in Behçet's syndrome: evaluating SII, SIRI, and NPAR

    Biomarkers in medicine, 2025

    DOI 10.1080/17520363.2025.2473312 PMID 40024670 5 citations (Europe PMC) Texte intégral en libre accèsSource : Europe PMC

  13. Obesity might not alter tofacitinib drug survival in rheumatoid arthritis patients

    Wiener klinische Wochenschrift, 2025

    DOI 10.1007/s00508-024-02424-3 PMID 39259223 2 citations (Europe PMC) Source : Europe PMC

  14. Retention rate and predictor factors of drug discontinuation in axial spondyloarthritis: a focus on certolizumab and secukinumab

    Reumatismo, 2025

    DOI 10.4081/reumatismo.2025.1792 PMID 40586484 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  15. Comorbidity Profile of Familial Mediterranean Fever Patients Varies by Treatments

    Hitit Medical Journal, 2025

    DOI 10.52827/hititmedj.1582847 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  16. The Role of Prognostic Nutritional Index in Vascular Behçet’s Syndrome

    Medical Records, 2025

    DOI 10.37990/medr.1593728 Texte intégral en libre accèsSource : OpenAlex

  17. Evaluation of digestive symptoms in patients with systemic sclerosis: A cross-sectional study

    Medicine Science | International Medical Journal, 2025

    DOI 10.5455/medscience.2024.12.156 Texte intégral en libre accèsSource : OpenAlex

  18. Serum Semaphorin 3A Levels in Patients with Behçet’s Disease with and without Vascular Involvement

    Bratislavské lekárske listy/Bratislava medical journal, 2025

    DOI 10.1007/s44411-025-00084-x Texte intégral en libre accèsSource : OpenAlex

  19. Seasonal variation in incidence and relapse of granulomatosis with polyangiitis: A retrospective cohort study from Central Anatolia.

    Sarcoidosis vasculitis and diffuse lung diseases, 2025

    DOI 10.36141/svdld.v42i2.16537 PMID 40699500 Texte intégral en libre accèsSource : OpenAlex

  20. What are the Anti-Rheumatic Drug Prescribing Patterns in Rheumatoid Arthritis Patients With Chronic Kidney Disease?: A Single-Center Cross-Sectional Study

    Medical Records, 2025

    DOI 10.37990/medr.1729553 Texte intégral en libre accèsSource : OpenAlex

  21. General Characteristics of Rheumatology Consultations in the Emergency Department: Retrospective Results of a Tertiary Hospital

    Archives of Current Medical Research, 2025

    DOI 10.47482/acmr.1659275 Texte intégral en libre accèsSource : OpenAlex

  22. Lupus nefriti klinik ve laboratuvar göstergelerinin incelenmesi: tek merkez deneyimi

    AYBU AVESIS, 2025

    Source : OpenAlex

  23. Behçet's disease beyond the criteria: insights from a tertiary centre in Turkey

    Clinical and Experimental Rheumatology, 2025

    DOI 10.55563/clinexprheumatol/h8mxc6 PMID 41066186 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  24. Effect of biological treatment on the thiol/disulfide parameters in patients with axial spondyloarthritis

    Immunopharmacology and Immunotoxicology, 2025

    DOI 10.1080/08923973.2025.2469211 PMID 39981891 Source : OpenAlex

  25. The Role of Central Sensitization in Autoimmune Connective Tissue Diseases: A Comparative Cross-Sectional Study

    International journal of rheumatic diseases, 2025

    DOI 10.1111/1756-185x.70069 PMID 39835488 3 citations (Europe PMC) Texte intégral en libre accèsSource : Europe PMC

  26. From Conventional to Advanced Therapies: A National Health Registry Report (2016-2022) on DMARDs in Rheumatoid Arthritis Treatment in Turkey

    Biologics : targets & therapy, 2025

    DOI 10.2147/btt.s507132 PMID 40452953 1 citation (Europe PMC) Texte intégral en libre accèsSource : Europe PMC

  27. 2023 International Rome consensus for the nomenclature of Sjögren disease

    Nature Reviews Rheumatology, 2025

    DOI 10.1038/s41584-025-01268-z PMID 40494962 109 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  28. Evaluation of serum total antioxidant level, nutritional status and Mediterranean diet adherence of adult women with rheumatoid arthritis: a case–control study

    British Journal Of Nutrition, 2025

    DOI 10.1017/s0007114524003386 PMID 39758032 11 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  29. Patients with suspected pulmonary hypertension based on echocardiography in Behçet's disease: a 5-year follow-up study

    Orphanet Journal of Rare Diseases, 2025

    DOI 10.1186/s13023-025-03825-x PMID 40500722 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  30. Immunological signatures in patients with Sjögren's disease: association with systemic disease activity at diagnosis

    Clinical and Experimental Rheumatology, 2025

    DOI 10.55563/clinexprheumatol/zx7cp9 PMID 41410589 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  31. Sex disparities in the phenotype at diagnosis of Sjögren's disease: artificial intelligence-driven characterisation in 17,416 patients

    Clinical and Experimental Rheumatology, 2025

    DOI 10.55563/clinexprheumatol/m8cq3f PMID 41410590 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  32. The role of high large unstained cell percentages in ongoing inflammation in the intercritical gout

    Joint Diseases and Related Surgery, 2025

    DOI 10.52312/jdrs.2025.2188 PMID 40235415 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  33. Evaluation of pregnancy planning and contraceptive methods in patients with systemic lupus erythematosus

    Gulhane Medical Journal, 2025

    DOI 10.4274/gulhane.galenos.2025.88156 Texte intégral en libre accèsSource : OpenAlex

  34. ABS1074 BEHÇET'S DISEASE BEYOND THE CRITERIA: INSIGHTS FROM A TERTIARY CENTER IN TURKEY

    Annals of the Rheumatic Diseases, 2025

    DOI 10.1016/j.ard.2025.06.958 Texte intégral en libre accèsSource : OpenAlex

  35. ABS0885 COMPLEMENT CONSUMPTION PATTERNS AS AN EARLY PREDICTOR OF SYSTEMIC SJÖGREN DISEASE: GENERATIVE ARTIFICIAL INTELLIGENCE-ASSISTED ANALYSIS USING STRATIFIED CROSS-VALIDATION GENERALIZABILITY MODELS

    Annals of the Rheumatic Diseases, 2025

    DOI 10.1016/j.ard.2025.06.1702 Texte intégral en libre accèsSource : OpenAlex

  36. POS0825 SEX DISPARITIES IN THE PHENOTYPE AT DIAGNOSIS OF SJÖGREN DISEASE: A GENERATIVE AI-DRIVEN CHARACTERIZATION IN 17,416 PATIENTS

    Annals of the Rheumatic Diseases, 2025

    DOI 10.1016/j.ard.2025.06.181 Texte intégral en libre accèsSource : OpenAlex

  37. POS1213 WHAT HAS THE FDA'S BLACK BOX WARNINGS FOR JAKi CHANGED IN REAL LIFE HÜR-BIO REAL-LIFE EXPERIENCE

    Annals of the Rheumatic Diseases, 2025

    DOI 10.1016/j.ard.2025.06.563 Texte intégral en libre accèsSource : OpenAlex

  38. POS0827 AUTOANTIBODY-COMBINED SIGNATURES DELINEATING IMMUNOLOGIC CLUSTERS RELATED TO HIGH SYSTEMIC ACTIVITY IN PATIENTS WITH SJÖGREN DISEASE

    Annals of the Rheumatic Diseases, 2025

    DOI 10.1016/j.ard.2025.06.183 Texte intégral en libre accèsSource : OpenAlex

  39. Unveiling cancer risk in ANCA-associated vasculitis: result from the Turkish Vasculitis Study Group (TRVaS)

    Internal and Emergency Medicine, 2024

    DOI 10.1007/s11739-024-03577-9 PMID 38553624 5 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  40. POS0218 VENOUS THROMBOEMBOLISM IN ANCA-ASSOCIATED VASCULITIS MIGHT BE ASSOCIATED WITH DISEASE ACTIVITY: RESULTS OF TR-VaS COHORT

    Annals of the Rheumatic Diseases, 2024

    DOI 10.1136/annrheumdis-2024-eular.2661 Source : OpenAlex

  41. The impact of histopathological criteria for definite vasculitis in giant cell arteritis: retrospective analysis of temporal artery biopsies

    Rheumatology international, 2024

    DOI 10.1007/s00296-024-05708-z PMID 39245763 1 citation (Europe PMC) Source : Europe PMC

  42. Reliability and validity of the Turkish version of Scleroderma Skin Patient-Reported Outcome in patients with systemic sclerosis

    Archives of rheumatology, 2024

    DOI 10.46497/archrheumatol.2023.10183 PMID 38774706 1 citation (Europe PMC) Texte intégral en libre accèsSource : Europe PMC

  43. Interstitial Lung Disease in Primary Sjögren's Syndrome: Risk factors for occurrence and radiographic progression.

    Sarcoidosis vasculitis and diffuse lung diseases, 2024

    DOI 10.36141/svdld.v41i3.15548 PMID 39315979 3 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  44. The burden of face affected questionnaire in patients with systemic sclerosis: Translation, cross-cultural adaptation and psychometric properties in the Turkish version

    The Egyptian Rheumatologist, 2024

    DOI 10.1016/j.ejr.2024.01.002 1 citation (OpenAlex) Source : OpenAlex

  45. Comorbidity Profiles in Inflammatory Rheumatic Diseases: An Analytical Perspective

    International Journal of Clinical Practice, 2024

    DOI 10.1155/2024/3244597 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  46. FACIAL ERYTHEMA MAY NOT ALWAYS BE A MANIFESTATION OF THE PRIMARY CONDITION IN CONNECTIVE TISSUE DISEASES: KEEP DEMODEX IN MIND!

    2024

    DOI 10.22541/au.170668061.18884453/v1 Texte intégral en libre accèsSource : OpenAlex

  47. Effects of intrauterine device use on attack frequency and severity ın woman of reproductive age with familial Mediterranean fever

    Archives of Gynecology and Obstetrics, 2024

    DOI 10.1007/s00404-024-07413-5 PMID 38478158 Source : OpenAlex

  48. Coronavirus Disease 2019 Outcomes in Amyloid A Protein Amyloidosis Secondary to Rheumatic Conditions and Signs of Post- Coronavirus Disease 2019 Proteinuria Progression

    European Journal of Rheumatology, 2024

    DOI 10.5152/eurjrheum.2024.23050 PMID 38705968 Texte intégral en libre accèsSource : OpenAlex

  49. AB1345 COMORBIDITY PROFILES IN INFLAMMATORY RHEUMATIC DISEASES: AN ANALYTICAL PERSPECTIVE

    Annals of the Rheumatic Diseases, 2024

    DOI 10.1136/annrheumdis-2024-eular.2373 Source : OpenAlex

  50. AB1327 VALIDATION OF THE 2022 ACR/EULAR CLASSIFICATION CRITERIA FOR LARGE-VESSEL VASCULITIS; CONFUSION OF CLASSIFICATION BETWEEN CERTAIN AGES REMAINS

    Annals of the Rheumatic Diseases, 2024

    DOI 10.1136/annrheumdis-2024-eular.5776 Source : OpenAlex